APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032

27 December 2025114 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Diagnosis Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Radiopharmaceuticals for Diagnosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiopharmaceuticals for Diagnosis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceuticals for Diagnosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceuticals for Diagnosis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiopharmaceuticals for Diagnosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiopharmaceuticals for Diagnosis Market by Company

Atom High-tech Co., Ltd.

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Tianjin Said Biopharmaceutical Co., Ltd.

Shenzhen Larven Bioengineering Technology Co., Ltd.

Shanghai Atom Kexing Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd.

Ningbo Jun'an Pharmaceutical Technology Co., Ltd.

Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.

Guangdong Xi'ai Pharmaceutical Co., Ltd.

Chengdu Zhonghe Gaotong Isotope Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Xinke Pharmaceutical Co., Ltd.

Beijing Zhibo High-tech Biotechnology Co., Ltd.

RadioMedix, Inc.

PDRadiopharma Inc.

Lantheus

Jubilant Radiopharma

GE Healthcare Ltd

DOE IP

Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride

Sodium Iodide [131I]

Iodine [125I] Sealed Seed Source

Technetium [99mTc] Pentetate

Technetium [99mTc] Polymerized Albumin

Technetium [99mTc] Dithiodithiocarbamate

Other

Radiopharmaceuticals for Diagnosis Segment by Application

Hospital

Clinic

Other

Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Strontium [89Sr] Chloride Table 2. Major Company of Sodium Iodide [131I] Table 3. Major Company of Iodine [125I] Sealed Seed Source Table 4. Major Company of Technetium [99mTc] Pentetate Table 5. Major Company of Technetium [99mTc] Polymerized Albumin Table 6. Major Company of Technetium [99mTc] Dithiodithiocarbamate Table 7. Major Company of Other Table 8. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 10. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type (2021-2026) Table 11. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 12. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type (2021-2026) Table 13. Global Radiopharmaceuticals for Diagnosis Price by Type (2021-2026) & (US$/Unit) Table 14. Global Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 15. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type (2027-2032) Table 16. Global Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (US$ Million) Table 17. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type (2027-2032) Table 18. Global Radiopharmaceuticals for Diagnosis Price by Type (2027-2032) & (US$/Unit) Table 19. North America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 20. North America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 22. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 26. Latin America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 29. Radiopharmaceuticals for Diagnosis Industry Trends Table 30. Radiopharmaceuticals for Diagnosis Industry Drivers Table 31. Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges Table 32. Radiopharmaceuticals for Diagnosis Industry Restraints Table 33. Global Radiopharmaceuticals for Diagnosis Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company (2021-2026) Table 35. Global Radiopharmaceuticals for Diagnosis Sales by Company (2021-2026) & (K Units) Table 36. Global Radiopharmaceuticals for Diagnosis Sales Share by Company (2021-2026) Table 37. Global Radiopharmaceuticals for Diagnosis Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Radiopharmaceuticals for Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Radiopharmaceuticals for Diagnosis Major Company Production Sites and Headquarters Table 40. Global Radiopharmaceuticals for Diagnosis Company, Product Type & Application Table 41. Global Radiopharmaceuticals for Diagnosis Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Radiopharmaceuticals for Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Radiopharmaceuticals for Diagnosis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units) Table 46. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Region (2021-2026) Table 47. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (US$ Million) Table 48. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Region (2021-2026) Table 49. Global Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032) & (K Units) Table 51. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Region (2027-2032) Table 52. Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032) & (US$ Million) Table 53. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Region (2027-2032) Table 54. Global Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 57. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application (2021-2026) Table 58. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 59. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application (2021-2026) Table 60. Global Radiopharmaceuticals for Diagnosis Price by Application (2021-2026) & (US$/Unit) Table 61. Global Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 62. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application (2027-2032) Table 63. Global Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (US$ Million) Table 64. Global Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application (2027-2032) Table 65. Global Radiopharmaceuticals for Diagnosis Price by Application (2027-2032) & (US$/Unit) Table 66. North America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 67. North America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 69. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 73. Latin America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 76. Atom High-tech Co., Ltd. Company Information Table 77. Atom High-tech Co., Ltd. Business Overview Table 78. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 80. Atom High-tech Co., Ltd. Recent Development Table 81. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information Table 82. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview Table 83. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio Table 85. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Development Table 86. Tianjin Said Biopharmaceutical Co., Ltd. Company Information Table 87. Tianjin Said Biopharmaceutical Co., Ltd. Business Overview Table 88. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 90. Tianjin Said Biopharmaceutical Co., Ltd. Recent Development Table 91. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information Table 92. Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview Table 93. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 95. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Development Table 96. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information Table 97. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview Table 98. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 100. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Development Table 101. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information Table 102. Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview Table 103. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 105. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Development Table 106. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information Table 107. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview Table 108. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 110. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Development Table 111. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information Table 112. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview Table 113. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 115. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Development Table 116. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information Table 117. Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview Table 118. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 120. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Development Table 121. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information Table 122. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview Table 123. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 125. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Development Table 126. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information Table 127. Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview Table 128. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 130. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Development Table 131. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information Table 132. Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview Table 133. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 135. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Development Table 136. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information Table 137. Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview Table 138. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 140. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Development Table 141. RadioMedix, Inc. Company Information Table 142. RadioMedix, Inc. Business Overview Table 143. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 145. RadioMedix, Inc. Recent Development Table 146. PDRadiopharma Inc. Company Information Table 147. PDRadiopharma Inc. Business Overview Table 148. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 150. PDRadiopharma Inc. Recent Development Table 151. Lantheus Company Information Table 152. Lantheus Business Overview Table 153. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio Table 155. Lantheus Recent Development Table 156. Jubilant Radiopharma Company Information Table 157. Jubilant Radiopharma Business Overview Table 158. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio Table 160. Jubilant Radiopharma Recent Development Table 161. GE Healthcare Ltd Company Information Table 162. GE Healthcare Ltd Business Overview Table 163. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio Table 165. GE Healthcare Ltd Recent Development Table 166. DOE IP Company Information Table 167. DOE IP Business Overview Table 168. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio Table 170. DOE IP Recent Development Table 171. North America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 173. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 174. North America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 176. North America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Radiopharmaceuticals for Diagnosis Market Share by Country (2021-2026) Table 179. North America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Radiopharmaceuticals for Diagnosis Market Share Forecast by Country (2027-2032) Table 181. Europe Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 183. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 184. Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Radiopharmaceuticals for Diagnosis Market Share by Country (2021-2026) Table 189. Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Radiopharmaceuticals for Diagnosis Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Share by Country (2021-2026) Table 199. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Share Forecast by Country (2027-2032) Table 201. Latin America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 203. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 204. Latin America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Radiopharmaceuticals for Diagnosis Market Share by Country (2021-2026) Table 209. Latin America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Radiopharmaceuticals for Diagnosis Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Share by Country (2021-2026) Table 219. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Radiopharmaceuticals for Diagnosis Distributors List Table 224. Radiopharmaceuticals for Diagnosis Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Radiopharmaceuticals for Diagnosis Image Figure 2. Global Radiopharmaceuticals for Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals for Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals for Diagnosis Sales (2021-2032) & (K Units) Figure 5. Strontium [89Sr] Chloride Image Figure 6. Global Strontium [89Sr] Chloride Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sodium Iodide [131I] Image Figure 8. Global Sodium Iodide [131I] Sales YoY Growth (2021-2032) & (K Units) Figure 9. Iodine [125I] Sealed Seed Source Image Figure 10. Global Iodine [125I] Sealed Seed Source Sales YoY Growth (2021-2032) & (K Units) Figure 11. Technetium [99mTc] Pentetate Image Figure 12. Global Technetium [99mTc] Pentetate Sales YoY Growth (2021-2032) & (K Units) Figure 13. Technetium [99mTc] Polymerized Albumin Image Figure 14. Global Technetium [99mTc] Polymerized Albumin Sales YoY Growth (2021-2032) & (K Units) Figure 15. Technetium [99mTc] Dithiodithiocarbamate Image Figure 16. Global Technetium [99mTc] Dithiodithiocarbamate Sales YoY Growth (2021-2032) & (K Units) Figure 17. Other Image Figure 18. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Radiopharmaceuticals for Diagnosis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Radiopharmaceuticals for Diagnosis Market Share by Type 2025 VS 2032 Figure 21. North America Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type in 2025 Figure 22. North America Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type in 2025 Figure 23. Europe Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type in 2025 Figure 24. Europe Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type in 2025 Figure 27. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Radiopharmaceuticals for Diagnosis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Radiopharmaceuticals for Diagnosis Market Share by Application 2025 VS 2032 Figure 41. North America Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application in 2025 Figure 42. North America Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application in 2025 Figure 43. Europe Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application in 2025 Figure 44. Europe Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application in 2025 Figure 47. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share in Value by Application in 2025 Figure 51. North America Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Radiopharmaceuticals for Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Radiopharmaceuticals for Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Radiopharmaceuticals for Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Radiopharmaceuticals for Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Radiopharmaceuticals for Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Radiopharmaceuticals for Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Radiopharmaceuticals for Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Radiopharmaceuticals for Diagnosis Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Radiopharmaceuticals for Diagnosis Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Strontium [89Sr] Chloride
  • Sodium Iodide [131I]
  • Iodine [125I] Sealed Seed Source
  • Technetium [99mTc] Pentetate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Dithiodithiocarbamate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Atom High-tech Co., Ltd.
  • Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  • Tianjin Said Biopharmaceutical Co., Ltd.
  • Shenzhen Larven Bioengineering Technology Co., Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  • Shanghai Xinke Pharmaceutical Co., Ltd.
  • Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  • Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  • Guangdong Xi'ai Pharmaceutical Co., Ltd.
  • Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  • Chengdu Yunke Pharmaceutical Co., Ltd.
  • Chengdu Xinke Pharmaceutical Co., Ltd.
  • Beijing Zhibo High-tech Biotechnology Co., Ltd.
  • RadioMedix, Inc.
  • PDRadiopharma Inc.
  • Lantheus
  • Jubilant Radiopharma
  • GE Healthcare Ltd
  • DOE IP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiopharmaceuticals for Diagnosis Market by Type
  6. 1.3.1 Strontium [89Sr] Chloride
  7. 1.3.2 Sodium Iodide [131I]
  8. 1.3.3 Iodine [125I] Sealed Seed Source
  9. 1.3.4 Technetium [99mTc] Pentetate
  10. 1.3.5 Technetium [99mTc] Polymerized Albumin
  11. 1.3.6 Technetium [99mTc] Dithiodithiocarbamate
  12. 1.3.7 Other
  13. 1.4 Global Radiopharmaceuticals for Diagnosis Market Size by Type
  14. 1.4.1 Global Radiopharmaceuticals for Diagnosis Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiopharmaceuticals for Diagnosis Industry Trends
  2. 2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
  3. 2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiopharmaceuticals for Diagnosis Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiopharmaceuticals for Diagnosis Sales (2021-2026)
  3. 3.3 Global Top Players by Radiopharmaceuticals for Diagnosis Price (2021-2026)
  4. 3.4 Global Radiopharmaceuticals for Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceuticals for Diagnosis Major Company Production Sites & Headquarters
  6. 3.6 Global Radiopharmaceuticals for Diagnosis Company, Product Type & Application
  7. 3.7 Global Radiopharmaceuticals for Diagnosis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals for Diagnosis Regional Status and Outlook
  1. 4.1 Global Radiopharmaceuticals for Diagnosis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size by Region
  3. 4.2.1 Global Radiopharmaceuticals for Diagnosis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiopharmaceuticals for Diagnosis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiopharmaceuticals for Diagnosis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Region
  7. 4.3.1 Global Radiopharmaceuticals for Diagnosis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiopharmaceuticals for Diagnosis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiopharmaceuticals for Diagnosis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiopharmaceuticals for Diagnosis by Application
  1. 5.1 Radiopharmaceuticals for Diagnosis Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 5.2.1 Global Radiopharmaceuticals for Diagnosis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Atom High-tech Co., Ltd.
  2. 6.1.1 Atom High-tech Co., Ltd. Company Information
  3. 6.1.2 Atom High-tech Co., Ltd. Business Overview
  4. 6.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  6. 6.1.5 Atom High-tech Co., Ltd. Recent Developments
  7. 6.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  8. 6.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
  9. 6.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
  10. 6.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
  12. 6.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
  13. 6.3 Tianjin Said Biopharmaceutical Co., Ltd.
  14. 6.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  18. 6.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
  20. 6.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
  21. 6.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
  22. 6.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  24. 6.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
  25. 6.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  26. 6.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  30. 6.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shanghai Xinke Pharmaceutical Co., Ltd.
  32. 6.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  36. 6.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  38. 6.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
  39. 6.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
  40. 6.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  42. 6.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
  43. 6.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  44. 6.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  48. 6.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
  50. 6.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  54. 6.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  56. 6.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
  57. 6.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
  58. 6.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  60. 6.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
  61. 6.11 Chengdu Yunke Pharmaceutical Co., Ltd.
  62. 6.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  66. 6.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Chengdu Xinke Pharmaceutical Co., Ltd.
  68. 6.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  72. 6.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
  74. 6.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
  75. 6.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
  76. 6.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  78. 6.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
  79. 6.14 RadioMedix, Inc.
  80. 6.14.1 RadioMedix, Inc. Company Information
  81. 6.14.2 RadioMedix, Inc. Business Overview
  82. 6.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  84. 6.14.5 RadioMedix, Inc. Recent Developments
  85. 6.15 PDRadiopharma Inc.
  86. 6.15.1 PDRadiopharma Inc. Company Information
  87. 6.15.2 PDRadiopharma Inc. Business Overview
  88. 6.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  90. 6.15.5 PDRadiopharma Inc. Recent Developments
  91. 6.16 Lantheus
  92. 6.16.1 Lantheus Company Information
  93. 6.16.2 Lantheus Business Overview
  94. 6.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
  96. 6.16.5 Lantheus Recent Developments
  97. 6.17 Jubilant Radiopharma
  98. 6.17.1 Jubilant Radiopharma Company Information
  99. 6.17.2 Jubilant Radiopharma Business Overview
  100. 6.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
  102. 6.17.5 Jubilant Radiopharma Recent Developments
  103. 6.18 GE Healthcare Ltd
  104. 6.18.1 GE Healthcare Ltd Company Information
  105. 6.18.2 GE Healthcare Ltd Business Overview
  106. 6.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
  108. 6.18.5 GE Healthcare Ltd Recent Developments
  109. 6.19 DOE IP
  110. 6.19.1 DOE IP Company Information
  111. 6.19.2 DOE IP Business Overview
  112. 6.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
  114. 6.19.5 DOE IP Recent Developments
7 North America by Country
  1. 7.1 North America Radiopharmaceuticals for Diagnosis Sales by Country
  2. 7.1.1 North America Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  4. 7.1.3 North America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country
  6. 7.2.1 North America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country
  2. 8.1.1 Europe Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
  6. 8.2.1 Europe Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country
  2. 9.1.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country
  6. 9.2.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiopharmaceuticals for Diagnosis Sales by Country
  2. 10.1.1 South America Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  4. 10.1.3 South America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country
  6. 10.2.1 South America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country
  2. 11.1.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country
  6. 11.2.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
  2. 12.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiopharmaceuticals for Diagnosis Production Mode & Process
  7. 12.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiopharmaceuticals for Diagnosis Distributors
  10. 12.2.3 Radiopharmaceuticals for Diagnosis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst